Radiation Therapy for Modern Management of Bone Metastases
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 674
Special Issue Editor
Interests: gastrointestinal cancer; genitourinary tract cancer; technology advances in radiation oncology; MRI-guided-radiation oncology; lung cancer; breast cancer; precision radiotherapy
Special Issue Information
Dear Colleagues,
Bone metastases (BM) frequently occur during malignant disease. The incidence of BM is expected to rise in the future due to an increase in the survival rates of patients with cancer. Radiotherapy (RT) is a crucial part of the management of BM. RT can efficiently relieve pain and improve the quality of life of patients, thus forming a crucial part of palliative care in general. Moreover, recent insights suggest a clear effect on the improvement of the disease and overall survival by locally controlling single metastases, along with the administration of systemic therapies (thus including the ablative approach aiming for local control of BM) in oligometastatic settings. Finally, RT can play a role in improving the systemic effect of immune oncological therapy by the local treatment of lesions, including BM.
The clinical indications, the prescriptive optimal dose for each clinical sub-setting and different aim (e.g., palliation, local ablation and immune reaction stimulation), the target delineations and many other factors are still unclear, which makes investigating these issues an urgent challenge for modern oncologists and radiation oncologists in particular. Our Special Issue will deal these issues in this research field.
Dr. Francesco Cellini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- palliative care
- steretactic radiotherapy
- SBRT
- immunotherapy
- chemotherapy
- oligometastases
